bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · IEX Real-Time Price · USD
2.33
-0.07 (-2.92%)
At close: Feb 7, 2023, 4:00 PM
2.30
-0.03 (-1.29%)
After-hours: Feb 7, 2023, 7:46 PM EST
-2.92%
Market Cap 19.50M
Revenue (ttm) 2,457
Net Income (ttm) -12.06M
Shares Out 8.37M
EPS (ttm) -1.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,158
Open 2.40
Previous Close 2.40
Day's Range 2.25 - 2.47
52-Week Range 1.31 - 15.55
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BIAF

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas. [Read more]

Sector Healthcare
IPO Date Sep 1, 2022
Employees 11
Stock Exchange NASDAQ
Ticker Symbol BIAF
Full Company Profile

Financial Performance

Financial Statements

News

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced publication of “ Detection of early-stage lung cancer in sputum using automated flow cytometry and ...

2 weeks ago - Business Wire

bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced today that the U.S. Patent and Trademark Office (USPTO) has provided a Notice of Allowance for a patent a...

1 month ago - Business Wire

Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF) Click H...

1 month ago - PRNewsWire

bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lu...

1 month ago - Business Wire

bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lu...

2 months ago - Business Wire

bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lu...

3 months ago - Business Wire

bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company's Scientific and Medical Advisory Board

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--Sheila Habib, MD, and David Hill, MD, leaders in the lung cancer field, join the bioAffinity Technologies Scientific and Medical Advisory Board.

3 months ago - Business Wire

bioAffinity Technologies to Report Third Quarter 2022 Financial Results

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced that the Company will host a conference call and audio webcast on Monday, Nov. 14, 2022, at 8...

3 months ago - Business Wire

bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia

SAN ANTONIO, Texas--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced the People's Republic of China awarded a Certificate of Patent to the Company's wholly owned...

3 months ago - Business Wire

bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies presents results from flow cytometry analysis to detect diseases of the lung at CHEST Conference.

4 months ago - Business Wire

7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up

Penny sleeper stocks can offer tremendous risks to investors. However, much like any other speculative investment category, it's possible that traders can still generate incredible, perhaps life chang...

Other symbols: KGCMNKDRIGUEC
4 months ago - InvestorPlace

Why Is BioAffinity (BIAF) Stock Up 40% Today?

Early diagnosis specialist BioAffinity (NASDAQ: BIAF) spiked 60% on Wednesday morning before paring back some gains in the afternoon to around 40% up. Investors piled into BIAF stock upon the underly...

4 months ago - InvestorPlace

bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M

SAN ANTONIO, Texas--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies receives additional $7.7M from exercise of warrants, increasing total capital from IPO to approximately $15.6M

4 months ago - Business Wire

What Is Going on With bioAffinity (BIAF) Stock Today?

Source: CI Photos / Shutterstock.com BioAffinity (NASDAQ: BIAF) stock is rising higher on Wednesday after the cancer diagnostic company announced the publication of its research in PLOS ONE . This wa...

5 months ago - InvestorPlace

bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity publishes peer-reviewed results in PLOS ONE for evaluating lung health by using high-throughput flow cytometry to analyze sputum.

5 months ago - Business Wire

WallachBeth Capital Announces Closing Of bioAffinity Technologies, Inc. $7.8 Million Initial Public Offering

JERSEY CITY, N.J. , Sept. 6, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today bioAffinity Technologies, Inc. ("...

5 months ago - PRNewsWire

bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering

SAN ANTONIO--(BUSINESS WIRE)-- #IPO--Cancer diagnostic company bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), announces closing of $7.8 million IPO.

5 months ago - Business Wire

BIAF Stock Alert: 13 Things to Know Following bioAffinity's Red-Hot Debut

Source: CI Photos / Shutterstock.com BioAffinity Technologies (NASDAQ: BIAF) stock is ramping up on Friday as investors push shares higher following its IPO yesterday. That comes as several IPOs have...

5 months ago - InvestorPlace

bioAffinity (BIAF) Stock Pops 100% in Red-Hot IPO

Well, it turns out the initial public offering ( IPO) market isn't quite dead. The latest IPO to hit the markets today is that of bioAffinity (NASDAQ: BIAF).

5 months ago - InvestorPlace